• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有重度抑郁症患者的肠道微生物组变化:系统评价。

Gut microbiota variations in patients diagnosed with major depressive disorder-A systematic review.

机构信息

Centre for Clinical Research, North Denmark Regional Hospital, Hjoerring, Denmark.

Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

出版信息

Brain Behav. 2021 Jul;11(7):e02177. doi: 10.1002/brb3.2177. Epub 2021 May 28.

DOI:10.1002/brb3.2177
PMID:34047485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8323045/
Abstract

OBJECTIVE

The etiology of major depressive disorder (MDD) is multi-factorial and has been associated with a perturbed gut microbiota. Thus, it is therefore of great importance to determine any variations in gut microbiota in patients with MDD.

METHODS

A systematic literature search was conducted including original research articles based on gut microbiota studies performed in patients with MDD. Demographic and clinical characteristics, applied methodology and observed gut microbiota composition were compared between included studies.

RESULTS

Seventeen studies were included with a total of 738 patients with MDD and 782 healthy controls using different DNA purification methods, sequencing platforms and data analysis models. Four studies found a reduced α-diversity in patients with MDD, while gut microbiota compositions clustered separately according to β-diversity between patients and controls in twelve studies. Additionally, there was an increase in relative abundance of Eggerthella, Atopobium, and Bifidobacterium and a decreased relative abundance of Faecalibacterium in patients with MDD compared with healthy controls.

CONCLUSION

Gut microbiota differs significantly when comparing patients with MDD and healthy controls, though inconsistently across studies. The heterogeneity in gut microbiota compositions between the studies may be explained by variations in study design.

摘要

目的

重度抑郁症(MDD)的病因是多因素的,与肠道微生物群失调有关。因此,确定 MDD 患者肠道微生物群的任何变化非常重要。

方法

进行了系统的文献检索,包括基于 MDD 患者肠道微生物群研究的原始研究文章。对纳入研究之间的人口统计学和临床特征、应用方法和观察到的肠道微生物群组成进行了比较。

结果

共纳入 17 项研究,其中包括使用不同 DNA 纯化方法、测序平台和数据分析模型的 738 名 MDD 患者和 782 名健康对照者。四项研究发现 MDD 患者的α多样性降低,而 12 项研究中根据患者和对照者之间的β多样性,肠道微生物群组成聚类分开。此外,与健康对照者相比,MDD 患者的 Eggerthella、Atopobium 和双歧杆菌相对丰度增加,Faecalibacterium 相对丰度降低。

结论

与健康对照者相比,MDD 患者的肠道微生物群存在显著差异,但在研究间不一致。研究之间肠道微生物群组成的异质性可能解释了研究设计的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc89/8323045/d15474d91dfa/BRB3-11-e02177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc89/8323045/d15474d91dfa/BRB3-11-e02177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc89/8323045/d15474d91dfa/BRB3-11-e02177-g002.jpg

相似文献

1
Gut microbiota variations in patients diagnosed with major depressive disorder-A systematic review.患有重度抑郁症患者的肠道微生物组变化:系统评价。
Brain Behav. 2021 Jul;11(7):e02177. doi: 10.1002/brb3.2177. Epub 2021 May 28.
2
Omega-3 fatty acids for depression in adults.ω-3 脂肪酸治疗成人抑郁症。
Cochrane Database Syst Rev. 2021 Nov 24;11(11):CD004692. doi: 10.1002/14651858.CD004692.pub5.
3
Metagenomics reveals unique gut mycobiome biomarkers in major depressive disorder - a non-invasive method.宏基因组学揭示了重度抑郁症中独特的肠道真菌微生物组生物标志物——一种非侵入性方法。
Front Cell Infect Microbiol. 2025 Jun 4;15:1582522. doi: 10.3389/fcimb.2025.1582522. eCollection 2025.
4
A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia.一项关于肠道微生物群落组成的系统性综述,该综述观察了重性抑郁障碍、双相情感障碍和精神分裂症的研究。
Mol Psychiatry. 2022 Apr;27(4):1920-1935. doi: 10.1038/s41380-022-01456-3. Epub 2022 Feb 22.
5
The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies.抑郁症中的肠道微生物组及益生菌、益生元和合生制剂的潜在益处:临床试验和观察性研究的系统评价。
Int J Mol Sci. 2022 Apr 19;23(9):4494. doi: 10.3390/ijms23094494.
6
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
7
Control interventions in randomised trials among people with mental health disorders.精神障碍患者随机试验中的对照干预措施。
Cochrane Database Syst Rev. 2022 Apr 4;4(4):MR000050. doi: 10.1002/14651858.MR000050.pub2.
8
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
9
Effect of Fructooligosaccharides Supplementation on the Gut Microbiota in Human: A Systematic Review and Meta-Analysis.补充果寡糖对人类肠道微生物群的影响:系统评价和荟萃分析。
Nutrients. 2022 Aug 12;14(16):3298. doi: 10.3390/nu14163298.
10
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.

引用本文的文献

1
The development of an ingestible biosensor for the characterization of gut metabolites related to major depressive disorder: hypothesis and theory.用于表征与重度抑郁症相关的肠道代谢物的可摄入生物传感器的开发:假设与理论。
Front Syst Biol. 2023 Dec 5;3:1274184. doi: 10.3389/fsysb.2023.1274184. eCollection 2023.
2
Modulating depression through the gut-brain axis: the role of gut microbiota in therapeutic interventions.通过肠-脑轴调节抑郁症:肠道微生物群在治疗干预中的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 21. doi: 10.1007/s00210-025-04464-6.
3
Oral microbiome composition is associated with depressive symptoms during pregnancy.

本文引用的文献

1
Altered Composition of Gut Microbiota in Depression: A Systematic Review.抑郁症患者肠道微生物群组成的改变:一项系统综述。
Front Psychiatry. 2020 Jun 10;11:541. doi: 10.3389/fpsyt.2020.00541. eCollection 2020.
2
Crosstalk between the microbiota-gut-brain axis and depression.微生物群-肠道-脑轴与抑郁症之间的相互作用
Heliyon. 2020 Jun 3;6(6):e04097. doi: 10.1016/j.heliyon.2020.e04097. eCollection 2020 Jun.
3
Gut Microbiome Dysbiosis and Depression: a Comprehensive Review.肠道微生物群失调与抑郁症:全面综述。
口腔微生物群组成与孕期抑郁症状有关。
Brain Behav Immun Health. 2025 Mar 21;45:100978. doi: 10.1016/j.bbih.2025.100978. eCollection 2025 May.
4
Diet, Physical Activity and Depression: Does Gastrointestinal Health Help Explain the Relationship Between Lifestyle Factors and Depression?饮食、身体活动与抑郁症:胃肠道健康有助于解释生活方式因素与抑郁症之间的关系吗?
Nutr Bull. 2025 Jun;50(2):239-249. doi: 10.1111/nbu.12734. Epub 2025 Mar 4.
5
Dynamic human gut microbiome and immune shifts during an immersive psychosocial intervention program.沉浸式心理社会干预项目期间动态变化的人类肠道微生物群和免疫变化
Brain Behav Immun. 2025 Mar;125:428-443. doi: 10.1016/j.bbi.2024.12.027. Epub 2024 Dec 17.
6
Mechanism of Insomnia After Stroke Based on Intestinal Flora.基于肠道菌群的脑卒中后失眠机制
Int J Gen Med. 2024 Nov 25;17:5493-5502. doi: 10.2147/IJGM.S488714. eCollection 2024.
7
The gut microbiota-brain connection: insights into major depressive disorder and bipolar disorder.肠道微生物群与大脑的联系:对重度抑郁症和双相情感障碍的见解。
Front Psychiatry. 2024 Nov 5;15:1421490. doi: 10.3389/fpsyt.2024.1421490. eCollection 2024.
8
Microbiota and probiotics: chances and challenges - a symposium report.微生物群与益生菌:机遇与挑战——研讨会报告
Gut Microbiome (Camb). 2023 Mar 27;4:e6. doi: 10.1017/gmb.2023.4. eCollection 2023.
9
End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics.端到端供体筛选和生产控制:基于质量的互补策略,最大限度地降低供体衍生微生物组治疗产品的患者风险。
Gut Microbes. 2024 Jan-Dec;16(1):2402550. doi: 10.1080/19490976.2024.2402550. Epub 2024 Sep 18.
10
The Influence of Intestinal Microbiota on BDNF Levels.肠道微生物群对 BDNF 水平的影响。
Nutrients. 2024 Aug 29;16(17):2891. doi: 10.3390/nu16172891.
Curr Pain Headache Rep. 2020 Jun 6;24(7):36. doi: 10.1007/s11916-020-00871-x.
4
The human gut microbiota and depression: widely reviewed, yet poorly understood.人类肠道微生物群与抑郁症:广受关注,却知之甚少。
J Affect Disord. 2020 Sep 1;274:73-75. doi: 10.1016/j.jad.2020.05.115. Epub 2020 May 23.
5
Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression.肠道微生物特征可区分单相抑郁和双相抑郁。
Adv Sci (Weinh). 2020 Feb 5;7(7):1902862. doi: 10.1002/advs.201902862. eCollection 2020 Apr.
6
The gut microbiome and depression: finding a way through troubled waters where the river meets the sea.肠道微生物群与抑郁症:在河流与大海交汇的 troubled waters 中找到一条出路。 (注:这里“troubled waters”直译为“混乱的水域”,结合语境意译为“困境”更合适,但按要求不添加解释,保留原文表述)
Expert Rev Gastroenterol Hepatol. 2020 May;14(5):301-304. doi: 10.1080/17474124.2020.1754796. Epub 2020 Apr 16.
7
Reductions in anti-inflammatory gut bacteria are associated with depression in a sample of young adults.肠道抗炎细菌减少与年轻成年人的抑郁有关。
Brain Behav Immun. 2020 Aug;88:308-324. doi: 10.1016/j.bbi.2020.03.026. Epub 2020 Mar 27.
8
Current Perspectives on Gut Microbiome Dysbiosis and Depression.肠道微生物组失调与抑郁症的研究现状。
Adv Ther. 2020 Apr;37(4):1328-1346. doi: 10.1007/s12325-020-01272-7. Epub 2020 Mar 4.
9
Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls.抑郁中的炎症标志物:5166 名患者和 5083 名对照的平均差异和变异性的荟萃分析。
Brain Behav Immun. 2020 Jul;87:901-909. doi: 10.1016/j.bbi.2020.02.010. Epub 2020 Feb 27.
10
Reduced anti-inflammatory gut microbiota are associated with depression and anhedonia.促炎肠道微生物群减少与抑郁和快感缺失有关。
J Affect Disord. 2020 Apr 1;266:394-401. doi: 10.1016/j.jad.2020.01.137. Epub 2020 Jan 30.